Additionally, no increase in the expression of AR splice variant AR-V7 was observed in neoadjuvant resistant tumour foci, contrary to CRPC where increased AR-V7 is correlated with resistance to ADT [69,70]. This evidence concerns the gene AR and neoplasm.